We found that CAFs#1 to #4 (AKT2S128/CCTαS315/319/323-positive CAFs) produced the similar effect to induce the ESCC malignancy and impair the antitumor effect of FAK inhibitors in in vitro assays. The gene discussed is PTK2; the disease is esophageal squamous cell carcinoma.